Neural Regeneration Research: dFCS可用于AD诊断、治疗和持续评估

2022-08-30 影像小生 MedSci原创

动态连接强度的神经测量可能作为生物标志物,可用于AD的诊断、治疗和持续评估。

阿尔茨海默病是痴呆最常见的原因,其以进行性认知功能障碍和行为损害为特征,常影响生活及社会交往能力,经济负担重,无有效的治疗措施,已成为全球重大的社会公共卫生问题。目前多依靠临床诊断及一些辅助检查,如认知功能量表、生物学标记物、正电子发射型计算机断层显像等,但由于其敏感性、有创、昂贵等因素,使得无创的磁共振影像成为诊断阿尔茨海默病及早期很有前途的手段。功能磁共振技术可以通过测量血氧水平依赖信号无创地大脑的信息。

既往研究表明,静息态功能磁共振在发现阿尔茨海默病早期的生物标记物及发病机制方面潜力巨大,显示阿尔茨海默病患者中脑网络、脑区各功能连接异常。但这多是基于传统的功能连接,假设在短时间内功能连接相对稳定,忽略了认知的瞬间变化。

中国人民解放军总医院张熙教授团队联合北京师范大学认知神经科学与学习国家重点实验室舒妮团队就阿尔茨海默病、遗忘型轻型认知功能障碍患者进行动态功能连接异常表征的研究,并进一步就此进行机器学习分类研究。研究结果发表在Neural Regeneration Research

这项病例对照研究使用了动态功能连接(DFC)的新方法来寻找ADaMCI患者的异常。根据每个参与者的功能磁共振成像数据计算动态功能连接强度,然后使用支持向量机对AD患者和正常对照组进行分类。最后,强调了对分类贡献最大的大脑区域和大脑网络。

结果如下:

左楔前叶、默认网络和背侧注意网络的动态功能连接强度具有表征正常人、遗忘型轻型认知功能障碍和阿尔茨海默病差异的潜力。

  1. ADMCI患者左楔前叶dFCS方差明显低于NCs,且左楔前叶dFCS方差的变化与疾病严重程度相关。
  2. 特别是,部分相关分析显示,在控制了年龄、性别和教育作为混淆变量后,左楔前叶dFCS方差的变化与MMSE分数下降有关。
  3. 此外,训练两个SVM模型对ADaMCI进行分类。结果表明,AD-NC分类器的性能优于aMCI-NC分类器。脑区和脑网络的平均权重表明颞叶在ADMCI的发展过程中起着重要作用,而DMN和额顶叶网络在AD的发展过程中起着重要作用。

NC组、aMCI组和AD组的dFCS差异

楔前叶平均dFCS方差与MMSE (A)和MoCA (B)评分之间的相关性

决策值与MMSE (A)和MoCA(B)分数的相关性

动态功能连接强度在阿尔茨海默病和正常人分类中表现出了一定的能力,但在遗忘型轻型认知功能障碍和正常人中可靠性有待进一步研究。上述异常表征有望成为阿尔茨海默病早期诊断的影像学标志物值得研究。

总之,我们的结果表明,这些动态连接强度的神经测量可能作为生物标志物,可用于AD的诊断、治疗和持续评估。

 

原文出处

Cui Zhao, Wei-Jie Huang, Feng Feng, Bo Zhou, Hong-Xiang Yao, Yan-E Guo, Pan Wang, Lu-Ning Wang, Ni Shu, Xi Zhang. Abnormal characterization of dynamic functional connectivity in Alzheimer’s disease[J]. Neural Regeneration Research, 2022, 17(9): 2014-2021.

https://www.sjzsyj.com.cn/CN/10.4103/1673-5374.332161

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739153, encodeId=e95b1e39153ca, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Jun 21 19:32:17 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15154, encryptionId=d27515154f8, topicName=ratio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Sat Dec 03 09:32:17 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049420, encodeId=1ff9204942058, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Apr 08 23:32:17 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793181, encodeId=4f171e9318132, content=<a href='/topic/show?id=587a15268eb' target=_blank style='color:#2F92EE;'>#Regeneration#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15268, encryptionId=587a15268eb, topicName=Regeneration)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Mar 19 10:32:17 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557888, encodeId=7e23155e8885f, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Sep 01 00:32:17 CST 2022, time=2022-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739153, encodeId=e95b1e39153ca, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Jun 21 19:32:17 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15154, encryptionId=d27515154f8, topicName=ratio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Sat Dec 03 09:32:17 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049420, encodeId=1ff9204942058, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Apr 08 23:32:17 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793181, encodeId=4f171e9318132, content=<a href='/topic/show?id=587a15268eb' target=_blank style='color:#2F92EE;'>#Regeneration#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15268, encryptionId=587a15268eb, topicName=Regeneration)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Mar 19 10:32:17 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557888, encodeId=7e23155e8885f, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Sep 01 00:32:17 CST 2022, time=2022-09-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739153, encodeId=e95b1e39153ca, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Jun 21 19:32:17 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15154, encryptionId=d27515154f8, topicName=ratio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Sat Dec 03 09:32:17 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049420, encodeId=1ff9204942058, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Apr 08 23:32:17 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793181, encodeId=4f171e9318132, content=<a href='/topic/show?id=587a15268eb' target=_blank style='color:#2F92EE;'>#Regeneration#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15268, encryptionId=587a15268eb, topicName=Regeneration)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Mar 19 10:32:17 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557888, encodeId=7e23155e8885f, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Sep 01 00:32:17 CST 2022, time=2022-09-01, status=1, ipAttribution=)]
    2023-04-08 cy0324
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739153, encodeId=e95b1e39153ca, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Jun 21 19:32:17 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15154, encryptionId=d27515154f8, topicName=ratio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Sat Dec 03 09:32:17 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049420, encodeId=1ff9204942058, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Apr 08 23:32:17 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793181, encodeId=4f171e9318132, content=<a href='/topic/show?id=587a15268eb' target=_blank style='color:#2F92EE;'>#Regeneration#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15268, encryptionId=587a15268eb, topicName=Regeneration)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Mar 19 10:32:17 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557888, encodeId=7e23155e8885f, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Sep 01 00:32:17 CST 2022, time=2022-09-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1739153, encodeId=e95b1e39153ca, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Jun 21 19:32:17 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15154, encryptionId=d27515154f8, topicName=ratio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Sat Dec 03 09:32:17 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049420, encodeId=1ff9204942058, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Apr 08 23:32:17 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793181, encodeId=4f171e9318132, content=<a href='/topic/show?id=587a15268eb' target=_blank style='color:#2F92EE;'>#Regeneration#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15268, encryptionId=587a15268eb, topicName=Regeneration)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sun Mar 19 10:32:17 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557888, encodeId=7e23155e8885f, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Sep 01 00:32:17 CST 2022, time=2022-09-01, status=1, ipAttribution=)]
    2022-09-01 yangshch

相关资讯

Alzheimer’s & Dementia:社会经济地位低的区域痴呆症漏诊率、延误诊断率高

在社会经济地位低的城市可能存在大量的痴呆症漏诊。

梅斯专栏:神经新前沿——AD前沿

整合神经科诊疗资讯

四川大学华西医院:痴呆及阿尔茨海默病进展要点简析

四川大学华西医院对痴呆及阿尔茨海默病的研究进展进行综述,旨在提升大众对痴呆的总体认识。

华西皮肤论坛丨AD诊疗路径中关键要点中国共识解读

在2022年第五届华西皮肤论坛上,来自四川大学华西医院的王婷婷教授做了题为《AD诊疗路径中关键要点中国共识解读》的报道。

Alzheimer’s & Dementia:中年血脂和葡萄糖水平与阿尔茨海默病有关

从成年早期开始管理胆固醇和葡萄糖可以降低 AD 风险

华西皮肤论坛2022 丨冉玉平教授:审时“度”势——聚焦特应性皮炎长期管理

在2022第五届“华西皮肤论坛”会议上,四川大学华西医院皮肤性病科冉玉平教授以《审时“度”势-聚焦特应性皮炎长期管理》为题,对相关内容进行了详细的讲解。